LATARSHA EDWARDS: Open Payments
NPI 1376073072 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$405 in 23 payments from 7 companies in 2025. Trend: 2023 $30 · 2024 $0 · 2025 $405
Food & beverage: $405
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $169 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Vanda Pharmaceuticals Inc. | 3 | $63 |
| Bausch Health US, LLC | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Tris Pharma Inc | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: VRAYLAR, REXULTI, FANAPT, APLENZIN, Auvelity, Onyda XR, Qelbree.
Industry payments across TX — which companies pay providers there.
